Heart Failure: Oxford Specialist Handbooks in Cardiology
Autor Roy S. Gardner, Theresa A. McDonagh, Daniel J. Doherty, Niki L. Walkeren Limba Engleză Paperback – 16 oct 2025
Preț: 420.43 lei
Preț vechi: 536.78 lei
-22%
Puncte Express: 631
Carte disponibilă
Livrare economică 17-22 septembrie
Livrare express 28 august-03 septembrie pentru 119.14 lei
Livrare prin curier în România Termenul estimat este afișat lângă disponibilitate.
Transport gratuit pentru acest produs Plată online sau ramburs, în funcție de opțiunile comenzii.
Retur gratuit în 14 zile Comandă securizată și suport în română.
Specificații
ISBN-13: 9780192870773
ISBN-10: 0192870777
Pagini: 512
Dimensiuni: 100 x 180 x 20 mm
Greutate: 0.33 kg
Ediția:3rd edition
Editura: OUP OXFORD
Colecția OUP Oxford
Seria Oxford Specialist Handbooks in Cardiology
Locul publicării:Oxford, United Kingdom
ISBN-10: 0192870777
Pagini: 512
Dimensiuni: 100 x 180 x 20 mm
Greutate: 0.33 kg
Ediția:3rd edition
Editura: OUP OXFORD
Colecția OUP Oxford
Seria Oxford Specialist Handbooks in Cardiology
Locul publicării:Oxford, United Kingdom
Notă biografică
Professor Roy S. Gardner is a consultant cardiologist for the Scottish National Advanced Heart Failure Service at the Golden Jubilee National Hospital in Glasgow and an honorary professor at the University of Glasgow. He has a specialist interest and active research profile in advanced heart failure, cardiac transplantation, and complex devices. He is the past chair of the British Society for Heart Failure (BSH) and was awarded a lifetime Fellowship from the society 2023. He also serves on several European Society of Cardiology (ESC) committees and was the Taskforce Coordinator for the 2021 and 2023 ESC Heart Failure Guidelines.Professor Theresa A. McDonagh is a consultant cardiologist at King's College London. Her research interests are in clinical heart failure, in particular the epidemiology of heart failure and left ventricular dysfunction and the role of biomarkers. Prof McDonagh is currently chair of the Clinical Section of the Heart Failure Association of the ESC and clinical lead for the National Heart Failure Audit.Dr Daniel J. Doherty is a clinical research fellow at the University of Glasgow and cardiology speciality registrar in the west of Scotland. His interests include heart failure, complex devices and heart rhythm management, and he is currently undertaking a PhD examining the use of novel biomarkers for the detection of congestion in heart failure.Dr Niki L. Walker is a consultant cardiologist at the Scottish Adult Congenital Cardiac Service for Intervention and Cardiac Obstetrics at Golden Jubilee National Hospital. She has written numerous research works as part of the ESC.
Cuprins
- Section I - General Introduction
- 1.: Definition of heart failure: basic epidemiology and pathophysiology
- Section II - Chronic Heart Failure
- 2.: Diagnosis and investigation
- 3.: Estimating prognosis
- 4.: Non-pharmacological management
- 5.: Pharmacological management
- 6.: Device therapy
- 7.: Revascularisation
- 8.: Cardiac transplantation
- 9.: Mechanical circulatory support
- Section III - Heart failure and co-morbid/special conditions
- 10.: The patient with heart failure and angina
- 11.: The patient with heart failure and arrhythmias
- 12.: The patient with heart failure and arthritis
- 13.: The patient with heart failure and cancer
- 14.: The patient with heart failure and cardiomyopathy
- 15.: The patient with heart failure and congenital heart disease
- 16.: The patient with heart failure and diabetes mellitus
- 17.: The patient with heart failure and electrolyte disorders
- 18.: The patient with heart failure and infiltrative disease
- 19.: The patient with heart failure and iron deficiency / anaemia
- 20.: The patient with heart failure and myocarditis
- 21.: The patient with heart failure and obstructive lung disease
- 22.: The patient with heart failure and pregnancy
- 23.: The patient with heart failure and renal dysfunction
- 24.: The patient with heart failure and valvular disease
- Section IV - Acute heart failure
- 25.: Definition, aetiology, differing presentations and consequences
- 26.: Management
- Section V - Procedures
- 27.: Central venous cannulation
- 28.: Swan Ganz catheterisation
- 29.: Cardiac biopsy
- 30.: IABP insertion
- 31.: Cardiopulmonary exercise testing
- Section VI - Detailed pharmacology and evidence base for chronic heart failure
- 32.: ACE inhibitors
- 33.: ARNI
- 34.: ARBs
- 35.: Beta-adrenoreceptor antagonists
- 36.: Mineralocorticoid receptor antagonists
- 37.: SGLT2 inhibitors
- 38.: Diuretics and aquaretics
- 39.: Rate limiting agents
- 40.: Inotropes and vasopressors
- 41.: Vasodilators
- Section VI - Multiprofessional heart failure care
- 42.: Heart failure services
- 43.: Palliative care